A Leader in the Field
Our physicians are active members in the United Network for Organ Sharing (
UNOS), which oversees liver transplantation for liver cancer, and Michael P. Curry, MD, transplant hepatologist, is a UNOS regional representative. Drs. Curry and Rebecca A. Miksad, medical oncologist, participated in the 2008 UNOS HCC Consensus Conference to develop consensus on the best HCC (hepatocellular carcinoma or liver cancer) treatments. Dr. Miksad also took part in the 2008 National Institutes of Health HCC State-of-the-Art Conference to establish national research priorities and participates on the NIH Hepatobiliary Task Force.
BIDMC participates in the Eastern Cooperative Oncology Group (ECOG), the Radiation Therapy Oncology Group (RTOG), and the American College of Surgeons Oncology Group, and is a founding member of the Dana-Farber/Harvard Cancer Center (DF/HCC) – Harvard’s National Cancer Institute-designated comprehensive cancer center. We collaborate extensively on clinical trials with the DF/HCC.
